Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $754.2500 (-6.13%) ($754.2500 - $754.2500) on Thu. May. 4, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.62% (three month average) | RSI | 24 | Latest Price | $754.2500(-6.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1% a day on average for past five trading days. | Weekly Trend | REGN declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(47%) DIA(35%) VYM(34%) IWD(33%) | Factors Impacting REGN price | REGN will decline at least -0.81% in a week (0% probabilities). VXX(-29%) VIXM(-22%) TBT(-5%) UUP(-4%) ARKK(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.81% (StdDev 1.62%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $804.34 | 5 Day Moving Average | $792.81(-4.86%) | 10 Day Moving Average | $791.74(-4.74%) | 20 Day Moving Average | $804.34(-6.23%) | To recent high | -9.2% | To recent low | 2.4% | Market Cap | $79.972b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |